Alphamab Oncology

SHSC:9966 Voorraadrapport

Marktkapitalisatie: HK$3.5b

Alphamab Oncology Beheer

Beheer criteriumcontroles 2/4

Alphamab Oncology's CEO is Ting Xu, appointed in Nov 2008, has a tenure of 6.67 years. total yearly compensation is CN¥6.88M, comprised of 95.2% salary and 4.8% bonuses, including company stock and options. directly owns 33.06% of the company’s shares, worth HK$1.17B. The average tenure of the management team and the board of directors is 5.8 years and 5 years respectively.

Belangrijke informatie

Ting Xu

Algemeen directeur

CN¥6.9m

Totale compensatie

Percentage CEO-salaris95.2%
Dienstverband CEO16yrs
Eigendom CEO33.1%
Management gemiddelde ambtstermijn5.8yrs
Gemiddelde ambtstermijn bestuur5yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Ting Xu's beloning veranderd ten opzichte van Alphamab Oncology's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-CN¥216m

Mar 31 2024n/an/a

-CN¥213m

Dec 31 2023CN¥7mCN¥7m

-CN¥211m

Sep 30 2023n/an/a

-CN¥214m

Jun 30 2023n/an/a

-CN¥218m

Mar 31 2023n/an/a

-CN¥272m

Dec 31 2022CN¥7mCN¥6m

-CN¥326m

Sep 30 2022n/an/a

-CN¥309m

Jun 30 2022n/an/a

-CN¥292m

Mar 31 2022n/an/a

-CN¥352m

Dec 31 2021CN¥7mCN¥5m

-CN¥412m

Sep 30 2021n/an/a

-CN¥502m

Jun 30 2021n/an/a

-CN¥592m

Mar 31 2021n/an/a

-CN¥510m

Dec 31 2020CN¥5mCN¥4m

-CN¥428m

Sep 30 2020n/an/a

-CN¥652m

Jun 30 2020n/an/a

-CN¥877m

Mar 31 2020n/an/a

-CN¥851m

Dec 31 2019CN¥5mCN¥3m

-CN¥833m

Compensatie versus markt: Ting's total compensation ($USD969.89K) is above average for companies of similar size in the Hong Kong market ($USD399.57K).

Compensatie versus inkomsten: Ting's compensation has increased whilst the company is unprofitable.

CEO

Ting Xu (51 yo)

16yrs

Tenure

CN¥6,877,000

Compensatie

Dr. Ting Xu, Ph D., serves Chief Executive Officer at Alphamab Oncology since October 1, 2018. He Founded Alphamab Oncology in November 2008.Dr. Xu serves as Executive Director at Alphamab Oncology since...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Ting Xu
Founder16yrsCN¥6.88m33.06%
HK$ 1.2b
Yang Liu
VP of Corporate Operations & Executive Director6.1yrsCN¥2.97mgeen gegevens
Yumin Wan
Vice President of Government Affairs & Public Relations5.8yrsgeen gegevensgeen gegevens
Mike Liu
Senior Vice President of Business Development6.5yrsgeen gegevensgeen gegevens
Jing Han
Chief Commercial Officer3yrsgeen gegevensgeen gegevens
Lok Yee Chan
Joint Company Secretary4.3yrsgeen gegevensgeen gegevens
Qiulan Cheng
Joint Company Secretaryless than a yeargeen gegevensgeen gegevens

5.8yrs

Gemiddelde duur

51.5yo

Gemiddelde leeftijd

Ervaren management: 9966's management team is seasoned and experienced (5.8 years average tenure).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Ting Xu
Founder6.7yrsCN¥6.88m33.06%
HK$ 1.2b
Yang Liu
VP of Corporate Operations & Executive Director6.1yrsCN¥2.97mgeen gegevens
Cheng Wei
Independent Non-Executive Director5yrsCN¥396.00kgeen gegevens
Man Cho
Non-Executive Directorless than a yeargeen gegevens0.11%
HK$ 3.8m
Jason J. Luke
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Yiping Yang
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Dong Wu
Independent Non-Executive Director5yrsCN¥396.00kgeen gegevens
Lei Zheng
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Zihai Li
Chairman of Scientific Advisory Boardno datageen gegevensgeen gegevens
Zijian Guo
Independent Non-Executive Director3.3yrsCN¥378.00kgeen gegevens

5.0yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren bestuur: 9966's board of directors are considered experienced (5 years average tenure).